Get Premium to unlock powerful stock data
VistaGen Therapeutics Inc logo

VistaGen Therapeutics Inc

$ 1.05 -0.06 (-5.41%) 08:08 PM EST
P/E:
At Loss
P/B:
2.74
Market Cap:
$ 216.85M
Enterprise V:
$ 148.69M
Volume:
1.36M
Avg Vol (2M):
1.42M
Volume:
1.36M
Market Cap $:
216.85M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.42M
Enterprise Value $:
148.69M
PB Ratio:
2.74
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

VTGN Stock Institutional Ownership and Insider Ownership - VistaGen Therapeutics Inc

206.53
(Mil)
Shares Outstanding
26.23%
54.17 (Mil)
Institutional Ownership
0.22%
0.45 (Mil)
Insider Ownership
99.77%
206.045 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of VistaGen Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of VistaGen Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders